Corcept Therapeutics
CORT
CORT
193 hedge funds and large institutions have $1.2B invested in Corcept Therapeutics in 2019 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 67 increasing their positions, 62 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
8% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 62
6% more call options, than puts
Call options by funds: $4.41M | Put options by funds: $4.15M
0.24% less ownership
Funds ownership: 75.12% → 74.88% (-0.24%)
Holders
193
Holding in Top 10
2
Calls
$4.41M
Puts
$4.15M
Top Buyers
| 1 | +$18M | |
| 2 | +$13.2M | |
| 3 | +$7.55M | |
| 4 |
Millennium Management
New York
|
+$7.29M |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$3.42M |
Top Sellers
| 1 | -$32.1M | |
| 2 | -$14.5M | |
| 3 | -$7.97M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$5.79M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.22M |